UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037191
Receipt number R000042398
Scientific Title Rumination Focused Cognitive-Behavioral Therapy for Treatment-resistant Depression: A Pilot study
Date of disclosure of the study information 2019/06/27
Last modified on 2022/09/15 16:45:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Rumination Focused Cognitive-Behavioral Therapy for Treatment-resistant Depression: A Pilot study

Acronym

RFCBT-Pilot study

Scientific Title

Rumination Focused Cognitive-Behavioral Therapy for Treatment-resistant Depression: A Pilot study

Scientific Title:Acronym

Rumination Focused Cognitive-Behavioral Therapy for Treatment-resistant Depression: A Pilot study

Region

Japan


Condition

Condition

Treatment-resistant Depression

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety, efficacy and feasibility of Rumination Focused Cognitive-Behavioral Therapy for Treatment-resistant Depression

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

1. Baseline reduction score of GRID-Hamilton Depression Rating Scale (GRID-HAMD) at 16wk
2. Drop-out rate

Key secondary outcomes

1. Baseline reduction score of GRID-Hamilton Depression Rating Scale (GRID-HAMD) at 28 and 40wk
2. Beck Depression Inventory (BDI-II), Generalized Anxiety Disorder (GAD-7), Ruminative Responses Scale (RRS), Sheehan Disability Scale (SDISS), Cognitive-Behavioral Avoidance Scale (CBAS), Coping Inventory for Stressful Situations (CISS): 0,8,16,28,40 wks
3. Quick Inventory of Depressive Symptomatology (QIDS), Euro-Qol (EQ-5D), Session Rating Scale (SRS) at each session
4. Client satisfaction questionnaire (CSQ-8j): 0, 8,16 wks


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Rumination Focused Cognitive-Behavioral Therapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

1) having a diagnosis of DSM-IV Major Depressive Disorder confirmed with the SCID
2) have been treated with antidepressants or cognitive behavioral therapy for depression at least 8 weeks up to screening.
3) GRID-HAMD-17>=14
4) can attend session more than 8
5) 20 years old <= age <70 years old
6) can obtain written consent

Key exclusion criteria

1) No alcohol or substance use disorder in 12 months prior to the screening
2) No history or concurrent manic episode or psychotic disorders
3) No other primary DSM-IV Axis I Disorders at screening
4) No comorbid of antisocial personality disorder
5) No serious suicidal ideation at screening
6) No organic brain lesions or major cognitive deficits in a year prior to the screening
7) No severe or unstable medical co-morbidities at screening
8) No structured psychotherapy during the intervention.
9) Other relevant reason decided by the CBT principal investigator.

Target sample size

8


Research contact person

Name of lead principal investigator

1st name Atsuo
Middle name
Last name Nakagawa, MD, PhD

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-8582

Address

Shinanomachi 35, Shinjuku-ku, Tokyo, Japan

TEL

03-5363-3235

Email

anakagawa@keio.jp


Public contact

Name of contact person

1st name Atsuo
Middle name
Last name Nakagawa, MD, PhD

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-8582

Address

Shinanomachi 35, Shinjuku-ku, Tokyo, Japan

TEL

03-5363-3235

Homepage URL


Email

anakagawa@keio.jp


Sponsor or person

Institute

Keio University School of Medicine, Department of Neuropsychiatry

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine

Address

Shinanomachi 35, Shinjuku-ku, Tokyo, Japan

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学医学部・慶應義塾大学病院 (東京都)
Keio University School of Medicine, Department of Neuropsychiatry (Tokyo)


Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 05 Month 21 Day

Date of IRB

2019 Year 06 Month 24 Day

Anticipated trial start date

2019 Year 07 Month 04 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 06 Month 27 Day

Last modified on

2022 Year 09 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042398


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name